21 May 2013
Keywords: astex, signs, drug, discovery, collaboration, aventis, uk-based
Article | 01 April 2002
UK-based drug discovery company Astex Technology has signed a structuralbiology research agreement with Aventis that will focus on solving
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 April 2002
20 May 2013
© 2013 thepharmaletter.com